Tianjin Jinjin Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is SPIRONOLACTONE USP BULK API, with a corresponding US DMF Number 30192.
Remarkably, this DMF maintains an Active status since its submission on December 31, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 24, 2019, and payment made on July 20, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II